Inge Christoffer Olsen
Oslo University Hospital(NO)University of Oslo(NO)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Biosimilars and Bioanalytical Methods, COVID-19 Clinical Research Studies, Spondyloarthritis Studies and Treatments
Most-Cited Works
- → Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial(2017)793 cited
- → Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial(2016)289 cited
- → Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial(2020)229 cited
- → Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010(2013)183 cited
- → Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial(2022)160 cited
- → Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases